Gryphon Financial Partners LLC
Source: SEC Form 13F · as of Mar 2026Gryphon Financial Partners LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $61.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$61.8M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 91,042 | $19.8M |
| ABTABBOTT LABORATORIES | 121,866 | $12.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 29,735 | $8.0M |
| JNJJOHNSON & JOHNSON | 24,077 | $5.9M |
| LLYELI LILLY & Co | 5,668 | $5.2M |
| AMGNAMGEN INC | 5,860 | $2.1M |
| MRKMerck & Co., Inc. | 13,352 | $1.6M |
| PMPhilip Morris International Inc | 7,267 | $1.2M |
| GILDGILEAD SCIENCES, INC. | 6,068 | $846K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,856 | $829K |
| UTHRUNITED THERAPEUTICS Corp | 1,311 | $777K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 13,106 | $723K |
| PFEPFIZER INC | 13,204 | $371K |
| DGXQuest Diagnostics Incorporated | 1,813 | $355K |
| MCKMcKesson Corporation | 404 | $349K |
| ELVElevance Health Inc. | 999 | $293K |
| IDXXIDEXX LABORATORIES INC /DE | 472 | $265K |
| CAHCardinal Health Inc. | 1,239 | $262K |
| ZTSZoetis Inc. | 2,060 | $244K |
| CRMDCorMedix Inc. | 27,401 | $186K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.